Clinical Trials Logo

Hypertension clinical trials

View clinical trials related to Hypertension.

Filter by:

NCT ID: NCT05979142 Completed - Hypertension Clinical Trials

Community-based Primary Care Program Effects on Pharmacotherapy of Type 2 Diabetes and Hypertension in Peru

Start date: September 2011
Phase:
Study type: Observational

The goal of this observational study is to compare usual care to a community-based primary care program (having components of treatment decisions based on clinical guidelines, self-management education, community health workers, and free health care visits and medications) in low-income Peruvians with type 2 diabetes and/or hypertension. The main question[s] it aims to answer are: - Compared to pre-program usual care, does the program result in greater benefits, measured as greater proportions of patients with glucose and blood pressure control or maximal quantities and doses of medications? - Are there greater benefits when the program was provided at home compared to when the program was provided in a clinic? - Does longer participation in the program result in greater benefits? Participants will participate in: - Self-management education provided by community health workers. - Monitoring of healthy behaviors and glucose, blood pressure, and weight. - Receipt of free medications for blood pressure, glucose, and heart disease prevention.

NCT ID: NCT05977933 Not yet recruiting - Clinical trials for Pulmonary Arterial Hypertension

Assessing the Utility of Submaximal CPET in Treatment Management of PAH

Start date: April 1, 2024
Phase:
Study type: Observational

Pulmonary hypertension (PH) is associated with worsening breathlessness and exercise capacity, right-heart failure, and adverse outcomes including increased mortality. Moreover, PH disease progression can be rapid; pharmaceutical intervention in early-stage Pulmonary Hypertension (PH) can improve symptoms and functional capacity, and delayed diagnosis and treatment of Pulmonary Hypertension (PH) likely reduces survival.

NCT ID: NCT05976477 Not yet recruiting - Hypertension Clinical Trials

Reduction Of Dietary Salt Intake To Control Systolic Blood Pressure In Hypertensive Older Patients

REPRESS
Start date: October 1, 2023
Phase: N/A
Study type: Interventional

REPRESS is an open label, pragmatic, multicenter, randomized controlled phase III trial with blinded endpoint with 1:1 (intervention to control arm) allocation ratio. The REPRESS trial is aimed to determine the efficacy of an educational intervention aimed at reducing dietary salt intake in elderly people (60+) with moderate hypertension and exposed to polypharmacy (3+ drugs) in improving systolic BP control compared to an attention arm.

NCT ID: NCT05976438 Not yet recruiting - Hypertension Clinical Trials

Skin Sodium and Salt Sensitivity of Blood Pressure

INTREPID
Start date: August 2023
Phase: N/A
Study type: Interventional

Eating too much salt raises blood pressure and the risk of having a heart attack or stroke. The investigators do not fully understand why salt raises blood pressure, but storage of sodium in the body, particularly in the skin, may be important. For this reason, the investigators wish to study the link between skin sodium, blood pressure and cardiovascular risk in patients with high blood pressure, of different ethnicities, using techniques such as skin biopsy and magnetic resonance imaging (MRI). The results will provide detailed information on skin sodium storage and help us better understand the effects of blood pressure medications on these mechanisms. Ultimately, the investigators aim to develop personalized treatment guidelines for clinical use.

NCT ID: NCT05976230 Recruiting - Hypertension Clinical Trials

Special Drug Use Surveillance of Entresto Tablets (Hypertension)

ENLIGHT
Start date: September 4, 2023
Phase:
Study type: Observational

This is a single arm, multicenter, observational study to evaluate the safety and efficacy of Entresto Tablets during the first 52 weeks of treatment in Japanese patients with hypertension.

NCT ID: NCT05975905 Recruiting - Clinical trials for Pulmonary Arterial Hypertension

A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study).

Start date: October 17, 2023
Phase: Phase 2
Study type: Interventional

Study KER-012-A201 is Phase 2, double-blind, randomized, placebo-controlled study to determine the efficacy and safety of KER-012 compared to Placebo in adults with PAH (WHO Group 1 PH) on stable background PAH therapy. The study is divided into the Screening Period, Treatment Period, Extension Period, and Follow-Up Period.

NCT ID: NCT05973760 Recruiting - Hypertension Clinical Trials

Dietary Assessment and Prevention of Hypertension in Nigeria

Start date: July 23, 2023
Phase:
Study type: Observational

Contrary to North America and Europe, the prevalence of hypertension is rising in West Africa and, currently, there are no simple dietary assessment tools for clinicians to offer personalized dietary support to their patients. This study aims to: 1. Evaluate the feasibility and validate the a short dietary screening tool for hypertension for use in Nigerian clinics; and 2. Test the accuracy and estimate the potential value of the validated short dietary assessment tool in Nigeria clinics.

NCT ID: NCT05972785 Active, not recruiting - Breast Cancer Clinical Trials

Long-term Use of CCB and Breast Cancer Risk

Start date: July 1, 2022
Phase:
Study type: Observational

The goal of this retrospective observational study is to examine whether long-term calcium channel blocker (CCB) use is associated with the development of breast cancer amongst women enrolled in three longitudinal cohort studies in Australia and the Netherlands . The main questions it aims to answer are: - Is long-term CCB use associated with the development of breast cancer amongst women enrolled in three longitudinal cohort studies in Australia and the Netherlands and what is the dose-response nature of this association. - Does differences in the association between calcium channel blocker use and the development of breast cancer exist between Australian and Dutch women. The investigators will utilise data from the Australian Longitudinal Study on Women's Health (ALSWH) , 45 and Up Study and Rotterdam study.

NCT ID: NCT05971433 Enrolling by invitation - Hypertension Clinical Trials

Determining the Role of Sympathetic Activity in the Impact of Combat Injury on Sleep and Cardiovascular Outcomes

SPIRIT
Start date: April 1, 2024
Phase:
Study type: Observational

The goal of this observational study is to learn about the long-term health of United States military service members who were injured during combat. The main questions it aims to examine are: - How does the severity of a combat injury impact 1) cardiovascular risk, 2) the sympathetic nervous system and arrhythmias, 3) blood pressure, and 4) sleep disorders? - Are self-reported mental health symptoms related to sympathetic nervous system hyperactivity, sleep disorders, and cardiovascular risk in combat-injured service members? This study will recruit from a sample of participants in another research study called the Wounded Warrior Recovery Project (WWRP) who 1) agreed to be contacted about future research studies and 2) have a record of a combat injury within the Injury Severity Score ranges required for this study. Participants will: - Provide demographic information and a medical history review - Visit a local laboratory for biometrics measurements and to provide blood and urine samples - Wear an ambulatory electrocardiogram monitor for 24 hours per day for seven consecutive days - Wear a home sleep test monitoring device for one night - Wear a blood pressure monitor for 24 consecutive hours on the day after the home sleep test At the end of the study, participants will be asked to mail back the home sleep test and blood pressure monitors. Prepaid package materials will be provided.

NCT ID: NCT05971407 Recruiting - Hypertension Clinical Trials

The Effect of Chronic Remote Ischaemic Preconditioning on Blood Pressure in Older Adults

RIPCo
Start date: September 25, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether remote ischaemic conditioning, applied chronically, improves vascular health in older adults